ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MDNA Medicenna Therapeutics Corp

1.95
0.00 (0.00%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Medicenna Therapeutics Corp MDNA Toronto Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.95 06:30:05
Open Price Low Price High Price Close Price Previous Close
1.95
more quote information »

Recent News

Date Time Source Heading
4/26/202407:00GLOBEMedicenna Therapeutics Announces CA$20 Million Investment..
4/24/202409:05GLOBEMedicenna Announces Oral Presentation of MDNA11 Data from..
4/10/202405:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
4/09/202415:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
4/09/202411:01GLOBEMedicenna Presents Updated Preclinical Data on MDNA113, a..
4/04/202406:00GLOBEMedicenna to Present at the 2024 Bloom Burton & Co...
3/06/202406:00GLOBEMedicenna to Provide Clinical Update on the MDNA11 ABILITY-1..
2/14/202406:30GLOBEMedicenna Therapeutics Reports Third Quarter Fiscal 2024..
2/13/202406:00GLOBEMedicenna Announces First Patient Dosed in ABILITY-1 Study..
1/12/202416:36GLOBEMedicenna Announces Appointment of New Auditor
1/09/202406:00GLOBEMedicenna Commences Enrollment in the ABILITY-1 Study..
12/21/202318:30GLOBEMedicenna Extends Period to Exercise Certain Warrants
12/19/202306:00GLOBEMedicenna Announces Trading on the OTCQB Under the Symbol..
11/14/202307:30GLOBEMedicenna Therapeutics Reports Second Quarter Fiscal 2024..
11/09/202307:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
11/06/202306:00GLOBEMedicenna Announces Promising Single-Agent Response and..
11/03/202311:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
10/27/202306:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
10/25/202306:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
10/24/202306:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10/10/202306:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
10/03/202306:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
9/28/202316:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
9/28/202306:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
9/06/202306:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
8/28/202306:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
8/14/202306:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
8/08/202306:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
8/04/202306:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
8/01/202308:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
7/28/202306:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
7/25/202306:00GLOBEMedicenna Presents at National Brain Tumor Society's..
7/05/202306:00GLOBEMedicenna Extends Period to Exercise Certain Warrants
6/27/202307:00GLOBEMedicenna Reports Fiscal Year 2023 Financial Results and..
4/27/202306:00GLOBEMedicenna Granted 180-Day Extension to Meet Nasdaq Minimum..

Your Recent History

Delayed Upgrade Clock